= Emerging. More than 5 years before clinical availability. (16.60%, 2024)
= Expected to be clinically available in 1 to 4 years. (37.02%, 2024)
= Clinically available now. (46.38%, 2024)
MSACL 2024 : Grant

MSACL 2024 Abstract

Self-Classified Topic Area(s): Practical Training > Various OTHER

Podium Presentation in Colton on Thursday at 13:30 (Chair: Deborah French)

Everything you wanted to know about Internal Standards, but were too afraid to ask

Russ Grant
Labcorp, Burlington, NC

Russell Grant, PhD (Presenter)

Presenter Bio: Dr Grant earned a PhD in chromatographic and mass spectrometric technologies from the University of Swansea, Wales, United Kingdom. He continued his scientific training in various industrial settings, which have included senior scientist at GSK, principal scientist at Cohesive Technologies, technical director at Eli Lilly, and director of mass spectrometry at Esoterix Endocrinology.

Dr Grant has pioneered the use of direct injection technologies, chromatographic systems multiplexing, utility of automation, and new analytical platforms for application in bioanalytical applications. His research goals are focused upon improvements in speed, sensitivity, and quality of liquid chromatography with tandem mass spectrometric (LC-MS/MS) analytical systems and assays.


Structure: This one hour teaching session regarding Internal Standards will be delivered in three 20 minute vignettes. The first session will describe in detail the "What, Why and How" Internal standards should be used in isotope dilution LC-MS/MS assays. The second session "But what about when?" will describe situations where Internal Standards fail criterion for use and how to correct deficiencies for effective LC-MS/MS assays. The third session will describe the "Unique capabilities" afforded to analytical measurement when used as pre-analytic correction tools, internal calibrators, discrimination between recovery and ionization effects (duplicate IS's) and in method development (as surrogates for analytes).

Take Home Pearls: Key experimental considerations and "cause-effect" will be detailed to establish when internal standards are behaving in a manner consistent with the analyte.

Session 1 will include: What level should I add IS at? what does the IS actually do? Qualitative details and error observations, quantitative assessment of binding equivalency (Reverse admixing - and when it can be misleading), drift over time using dynamic extraction and automation tools (and how to both elucidate and correct errors).

Session 2 will highlight examples of internal standardization failures such as the impact of excessive labeling, Isotopic contribution (from and to analyte), and when to use an "analog" internal standard - correctly.

Session 3 will detail expanded uses of Internal standards such as differentiation between recovery error and ionization effects (to confidently determine release or repeat for patient results), in-plate dilution for results reporting outside the calibration range and how an internal standard can be used as a calibration system (and when not to!).

Financial Disclosure

Board Memberno
Stockyes Labcorp
IP Royaltyno

Planning to mention or discuss specific products or technology of the company(ies) listed above: